Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing
暂无分享,去创建一个
Timothy K Lu | T. Lu | S. Lemire | Hiroki Ando | Sebastien Lemire | Hiroki Ando | D. Pires | Diana P Pires
[1] T. Dean,et al. A Yersinia pestis-specific, lytic phage preparation significantly reduces viable Y. pestis on various hard surfaces experimentally contaminated with the bacterium , 2012, Bacteriophage.
[2] H. Krisch,et al. Genome plasticity in the distal tail fiber locus of the T-even bacteriophage: recombination between conserved motifs swaps adhesin specificity. , 1998, Journal of molecular biology.
[3] James J. Collins,et al. Dispersing biofilms with engineered enzymatic bacteriophage , 2007, Proceedings of the National Academy of Sciences.
[4] H. Brüssow. What is needed for phage therapy to become a reality in Western medicine? , 2012, Virology.
[5] R. Hausmann,et al. The gene for Klebsiella bacteriophage K11 RNA polymerase: Sequence and comparison with the homologous genes of phages T7, T3, and SP6 , 1990, Molecular and General Genetics MGG.
[6] Timothy K Lu,et al. The next generation of bacteriophage therapy. , 2011, Current opinion in microbiology.
[7] G. Church,et al. CRISPR/Cas9-Mediated Phage Resistance Is Not Impeded by the DNA Modifications of Phage T4 , 2014, PloS one.
[8] U. Fano,et al. Bacteriophage-Resistant Mutants in Escherichia Coli. , 1945, Genetics.
[9] D. G. Gibson. Oligonucleotide assembly in yeast to produce synthetic DNA fragments. , 2012, Methods in molecular biology.
[10] I. Molineux,et al. The Genome Sequence of Yersinia pestis Bacteriophage φA1122 Reveals an Intimate History with the Coliphage T3 and T7 Genomes , 2003, Journal of bacteriology.
[11] C. Richardson,et al. New Details about Bacteriophage T7-Host Interactions: Researchers are showing renewed interest in learning how phages interact with bacterial hosts, adapting to and overcoming their defenses , 2010 .
[12] D. Endy,et al. A fully decompressed synthetic bacteriophage øX174 genome assembled and archived in yeast. , 2012, Virology.
[13] Timothy B. Stockwell,et al. Complete Chemical Synthesis, Assembly, and Cloning of a Mycoplasma genitalium Genome , 2008, Science.
[14] Chad W. Euler,et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials , 2014, Nature Biotechnology.
[15] Mikael Skurnik,et al. Complete nucleotide sequence and likely recombinatorial origin of bacteriophage T3. , 2002, Journal of molecular biology.
[16] Irene A. Chen,et al. Inhibition of Bacterial Conjugation by Phage M13 and Its Protein g3p: Quantitative Analysis and Model , 2011, PloS one.
[17] R. Hausmann. The T7 Group , 1988 .
[18] Timothy K Lu,et al. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy , 2009, Proceedings of the National Academy of Sciences.
[19] F. D'Herelle. Bacteriophage as a Treatment in Acute Medical and Surgical Infections. , 1931, Bulletin of the New York Academy of Medicine.
[20] J. Morris,et al. MINIREVIEW Bacteriophage Therapy , 2001 .
[21] Mark J van Raaij,et al. Structural Characterization of the Bacteriophage T7 Tail Machinery*♦ , 2013, The Journal of Biological Chemistry.
[22] Molly K. Gibson,et al. The yin and yang of bacterial resilience in the human gut microbiota. , 2014, Journal of molecular biology.
[23] S. Moineau,et al. CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages , 2014, Nucleic acids research.
[24] Vincent Noireaux,et al. Genome replication, synthesis, and assembly of the bacteriophage T7 in a single cell-free reaction. , 2012, ACS synthetic biology.
[25] K. Miyanaga,et al. Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7. , 2005, Journal of biotechnology.
[26] C. Rm. Phage therapy: past history and future prospects. , 1999 .
[27] Bo Hu,et al. The Bacteriophage T7 Virion Undergoes Extensive Structural Remodeling During Infection , 2013, Science.
[28] Andrey P. Anisimov,et al. Identification of the Lipopolysaccharide Core of Yersinia pestis and Yersinia pseudotuberculosis as the Receptor for Bacteriophage φA1122 , 2011, Journal of bacteriology.
[29] H. Krisch,et al. The gp38 Adhesins of the T4 Superfamily: A Complex Modular Determinant of the Phage’s Host Specificity , 2011, Genome biology and evolution.
[30] M. Kleerebezem,et al. Microbiome and skin diseases , 2013, Current opinion in allergy and clinical immunology.
[31] T. Dinan,et al. Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .
[32] F. Studier,et al. Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. , 1983, Journal of molecular biology.
[33] M Unser,et al. Molecular substructure of a viral receptor-recognition protein. The gp17 tail-fiber of bacteriophage T7. , 1988, Journal of molecular biology.
[34] Schuyler F. Baldwin,et al. The Complete Genome Sequence of Escherichia coli DH10B: Insights into the Biology of a Laboratory Workhorse , 2008, Journal of bacteriology.
[35] Shun-Fu Chang,et al. A T3 and T7 Recombinant Phage Acquires Efficient Adsorption and a Broader Host Range , 2012, PloS one.
[36] U. Qimron,et al. Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system , 2014, RNA biology.
[37] M. Chamberlin,et al. Isolation of recombinants between T7 and T3 bacteriophages and their use in vitro transcriptional mapping , 1977, Journal of virology.
[38] J. Segre,et al. The human microbiome: our second genome. , 2012, Annual review of genomics and human genetics.
[39] Flavie Pouillot,et al. Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria. , 2010, Biosecurity and bioterrorism : biodefense strategy, practice, and science.
[40] R. Hendrix. Bacteriophage genomics. , 2003, Current opinion in microbiology.
[41] W. Bessler,et al. A bacteriophage-induced depolymerase active on Klebsiella K11 capsular polysaccharide. , 1973, Virology.
[42] R. Carlton,et al. Phage therapy: past history and future prospects. , 1999, Archivum immunologiae et therapiae experimentalis.
[43] Timothy K Lu,et al. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases , 2014, Nature Biotechnology.
[44] Christopher T. Walsh,et al. Antibiotics for Emerging Pathogens , 2009, Science.